Tecan Journal

High throughput hybridoma Generation

Tecan’s Freedom EVO® liquid handling platform has enabled Nurex to enhance its production of monoclonalantibodies, improving efficiency and increasing the number of clones obtained from each fusion. Nurex is a biotechnology company based in Sassari and Turin, Italy, that specializes in the production of advanced diagnostic tools for biomedical applications in genomics, proteomics and clinical diagnostics.